Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Frank-Raue

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Surgery|December 14, 2001
Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomasT Weber, T Schilling, K Frank-Raue, et al.
Nuclear Medicine Communications|June 1, 1993
The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinomaU Dörr, K Frank-Raue, F Raue, et al.
Deutsche Medizinische Wochenschrift (1946)|September 15, 2011
[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT]K Frank-Raue, G Leidig-Bruckner, A Lorenz, et al.
European Journal of Endocrinology|July 27, 2006
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotypeK Frank-Raue, H Buhr, H Dralle, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 17, 2009
New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumourK Frank-Raue, J Döhring, G Scheumann, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2AI Berndt, M Reuter, B Saller, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative studyU Dörr, S Würstlin, K Frank-Raue, et al.
Journal of Molecular Endocrinology|October 1, 1995
The human 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene cluster on chromosome 1p13 contains a presumptive pseudogene; 3 beta-HSD and CYP17 do not segregate with dominantly inherited hirsutismM W McBride, A J Russell, K Vass, et al.
Deutsche Medizinische Wochenschrift (1946)|September 26, 2003
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]K Frank-Raue, C Heimbach, S Rondot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potentialT M Behr, M Béhé, C Angerstein, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Surgery|December 14, 2001
Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomasT Weber, T Schilling, K Frank-Raue, et al.
Nuclear Medicine Communications|June 1, 1993
The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinomaU Dörr, K Frank-Raue, F Raue, et al.
Deutsche Medizinische Wochenschrift (1946)|September 15, 2011
[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT]K Frank-Raue, G Leidig-Bruckner, A Lorenz, et al.
European Journal of Endocrinology|July 27, 2006
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotypeK Frank-Raue, H Buhr, H Dralle, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 17, 2009
New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumourK Frank-Raue, J Döhring, G Scheumann, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2AI Berndt, M Reuter, B Saller, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative studyU Dörr, S Würstlin, K Frank-Raue, et al.
Journal of Molecular Endocrinology|October 1, 1995
The human 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene cluster on chromosome 1p13 contains a presumptive pseudogene; 3 beta-HSD and CYP17 do not segregate with dominantly inherited hirsutismM W McBride, A J Russell, K Vass, et al.
Deutsche Medizinische Wochenschrift (1946)|September 26, 2003
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]K Frank-Raue, C Heimbach, S Rondot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potentialT M Behr, M Béhé, C Angerstein, et al.
Pageof 5